Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins.

Viana SM, Montoya AL, Carvalho AM, de Mendon?a BS, Portillo S, Olivas JJ, Karimi NH, Estevao IL, Ortega-Rodriguez U, Carvalho EM, Dutra WO, Maldonaldo RA, Michael K, de Oliveira CI, Almeida IC. Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins. Emerg Microbes Infect. 2022 Dec; 11(1):2147-2159.

View in: PubMed

subject areas

Glycoproteins
Humans
Leishmania braziliensis
Leishmaniasis, Cutaneous
Serologic Tests

authors with profiles

Igor C. Almeida
Katja Michael

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support